CC
MD icon

Clearline Capital’s Pediatrix Medical MD Stock Holding History

Clearline Capital’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-89,721
Closed -$2.2M – 132
2020
Q4 		$2.2M Sell
89,721
-1,272,670
-93% -$23.9M 0.49% 55
2020
Q3 		$22.2M Buy
1,362,391
+440,869
+48% +$8.2M 5.82% 2
2020
Q2 		$15.8M Buy
921,522
+378,892
+70% +$5.62M 5.14% 3
2020
Q1 		$6.32M Buy
+542,630
New +$11.2M 2.92% 13

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Clearline Capital's MD Position: Q1 2021 in Review

Clearline Capital sold out of Pediatrix Medical (MD) in Q1 2021, closing a stake of 89,721 shares — an estimated $2.2M sold.

Clearline Capital first reported a position in MD in Q1 2020 and held it in 4 quarters. The position peaked at $22.2M in Q3 2020. 207 funds tracked by Wall St. Rank hold MD as of Q1 2021.

  • Clearline Capital reported no remaining Pediatrix Medical position as of Q1 2021 after selling out during the quarter.
  • Clearline Capital sold 89,721 Pediatrix Medical shares in Q1 2021, an estimated $2.2M.
  • Clearline Capital first reported a position in Pediatrix Medical in Q1 2020 and held it in 4 quarters.
  • Clearline Capital's Pediatrix Medical position peaked at $22.2M in Q3 2020.
  • 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2021.

Based on Clearline Capital's 13F filing for Q1 2021, filed 17 May 2021.